Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma ; volume:3 ; number:1 ; day:20 ; month:1 ; year:2015 ; pages:1-15 ; date:12.2015
Journal for ImmunoTherapy of Cancer ; 3, Heft 1 (20.1.2015), 1-15, 12.2015
- Creator
-
Jing, Weiqing
- Contributor
-
Gershan, Jill A.
Weber, James
Tlomak, Dominique
McOlash, Laura
Sabatos-Peyton, Catherine
Johnson, Bryon D.
SpringerLink (Online service)
- DOI
-
10.1186/s40425-014-0043-z
- URN
-
urn:nbn:de:1111-201610305264
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jing, Weiqing
- Gershan, Jill A.
- Weber, James
- Tlomak, Dominique
- McOlash, Laura
- Sabatos-Peyton, Catherine
- Johnson, Bryon D.
- SpringerLink (Online service)
Other Objects (12)
Immune checkpoint inhibitors for multiple myeloma immunotherapy
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer
BCMA-targeted immunotherapy for multiple myeloma
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
Enhanced cancer immunotherapy through synergistic ferroptosis and immune checkpoint blockade using cell membrane-coated nanoparticles
Cancer immunotherapy beyond immune checkpoint inhibitors
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Immune checkpoint inhibitors for multiple myeloma immunotherapy
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer
BCMA-targeted immunotherapy for multiple myeloma
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
Enhanced cancer immunotherapy through synergistic ferroptosis and immune checkpoint blockade using cell membrane-coated nanoparticles
Cancer immunotherapy beyond immune checkpoint inhibitors
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Immune checkpoint inhibitors for multiple myeloma immunotherapy
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer
BCMA-targeted immunotherapy for multiple myeloma
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
Enhanced cancer immunotherapy through synergistic ferroptosis and immune checkpoint blockade using cell membrane-coated nanoparticles
Cancer immunotherapy beyond immune checkpoint inhibitors